Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A1 | O15245 | 3/20 | 0.93 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.87 |
| ▸ | TP53 | P04637 | 1/20 | 0.87 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.87 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.87 |
| ▸ | TSHR | P16473 | 1/20 | 0.87 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.87 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.87 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.87 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.87 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.86 |
| ▸ | DNM1 | Q05193 | 8/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL70748 | 1.00 | SLC22A1 (0.93) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL13567361 | 1.00 | SLC22A1 (0.93) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL1060273 | 1.00 | SLC22A1 (0.93) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| Tetrahexylammonium SCHEMBL2521928 | 1.00 | SLC22A1 (0.93) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL332137 | 1.00 | SLC22A1 (0.93) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL1065743 | 1.00 | SLC22A1 (0.93) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL4059099 | 1.00 | SLC22A1 (0.93) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL1009645 | 1.00 | SLC22A1 (0.93) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL158607 | 1.00 | SLC22A1 (0.93) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL4685770 | 1.00 | SLC22A1 (0.93) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250122323-A1 | ONIUM SALT, BLOCKING AGENT DISSOCIATION CATALYST FOR BLOCKED ISOCYANATE, BLOCKED ISOCYANTE COMPOSITION INCLUDING BLOCKING AGENT DISSOCIATION CATALYST, THERMOSETTING RESIN COMPOSITION, AND CURED PRODUCT AND MANUFACTURING METHOD THEREFOR | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2025-04-17 | — | — | US | disclosed |
| US-12252632-B2 | Chemical-mechanical polishing composition, rinse composition, chemical- mechanical polishing method, and rinsing method | ENTEGRIS, INC. (US) | 2025-03-18 | — | — | US | disclosed |
| CN-117813334-A | Onium salt, blocking agent dissociation catalyst for blocking isocyanate, blocked isocyanate composition containing blocking agent dissociation catalyst, thermosetting resin composition, cured product, and method for producing same | 广荣化学株式会社 | 2024-04-02 | — | — | CN | disclosed |
| EP-3383442-B1 | USE OF (HETERO)POLYOXOMETALATES FOR SIMULTANEOUSLY IMPARTING ANTIMICROBIAL PROPERTIES TO, AND REDUCING THE GROWTH OF A BIOFILM ON A SURFACE OF A SUBSTRATE IN OR ON A HOME APPLIANCE | BSH HAUSGERAETE GMBH (DE) | 2023-06-21 | — | — | EP | disclosed |
| US-20220372329-A1 | CHEMICAL-MECHANICAL POLISHING COMPOSITION, RINSE COMPOSITION, CHEMICAL-MECHANICAL POLISHING METHOD, AND RINSING METHOD | ENTEGRIS, INC. | 2022-11-24 | — | — | US | disclosed |
| CN-114258421-A | Chemical mechanical polishing composition, cleaning composition, chemical mechanical polishing method and cleaning method | CMC材料株式会社 | 2022-03-29 | — | — | CN | disclosed |
| EP-3459423-B1 | HOUSEHOLD APPLIANCE WITH AN ANCHORED POLYOXOMETALATE CONTAINING COMPONENT PART, PROCESS FOR THE MANUFACTURE OF AN ANCHORED POLYOXOMETALATE AND PROCESSES FOR THE MANUFACTURE OF THE COMPONENT PART | BSH HAUSGERAETE GMBH (DE) | 2020-08-26 | — | — | EP | disclosed |
| EP-3459423-A1 | HOUSEHOLD APPLIANCE WITH AN ANCHORED POLYOXOMETALATE CONTAINING COMPONENT PART, PROCESS FOR THE MANUFACTURE OF AN ANCHORED POLYOXOMETALATE AND PROCESSES FOR THE MANUFACTURE OF THE COMPONENT PART | BSH Hausgeräte GmbH (DE) | 2019-03-27 | — | — | EP | disclosed |
| CN-104981475-B | Heteropolyoxometallate | POM专利管理公司 | 2018-10-26 | — | — | CN | disclosed |
| EP-3383442-A2 | USE OF (HETERO)POLYOXOMETALATES FOR SIMULTANEOUSLY IMPARTING ANTIMICROBIAL PROPERTIES TO, AND REDUCING THE GROWTH OF A BIOFILM ON A SURFACE OF A SUBSTRATE IN OR ON A HOME APPLIANCE | BSH Hausgeräte GmbH (DE) | 2018-10-10 | — | — | EP | disclosed |
| EP-2953956-B1 | HETEROPOLYOXOMETALATES | POM PATENTVERWALTUNGS GBR (DE) | 2016-12-28 | — | — | EP | disclosed |
| US-20160009669-A1 | ONIUM SALT, LIQUID COMPOSITION CONTAINING SAID ONIUM SALT AND CELLULOSE, AND CELLULOSE RECOVERY METHOD | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2016-01-14 | — | — | US | disclosed |
| US-20150373987-A1 | HETEROPOLYOXOMETALATES | POM PATENTVERWALTUNGS GBR (DE) | 2015-12-31 | — | — | US | disclosed |
| EP-2953956-A1 | HETEROPOLYOXOMETALATES | POM Patentverwaltungs GbR (DE) | 2015-12-16 | — | — | EP | disclosed |
| CN-104981475-A | Heteropolyoxometalates | POM PATENTVERWALTUNGS GBR | 2015-10-14 | — | — | CN | disclosed |
| WO-2014122225-A1 | HETEROPOLYOXOMETALATES | ITICON GMBH (DE) | 2014-08-14 | — | — | WO | disclosed |
| WO-2009040107-A2 | METHOD FOR THE PRODUCTION OF METAL-CONTAINING NANOPARTICLES | ALBERT-LUDWIGS-UNIVERSITÄT FREIBURG (DE) | 2009-04-02 | — | — | WO | disclosed |
| WO-2009024312-A2 | METHOD FOR THE PRODUCTION AND STABILIZATION OF FUNCTIONAL METAL NANOPARTICLES IN IONIC LIQUIDS | ALBERT-LUDWIGS-UNIVERSITÄT FREIBURG (DE) | 2009-02-26 | — | — | WO | disclosed |
| WO-2007006418-A1 | IONIC-LIQUID-CONTAINING PRODUCTS FOR DYEING AND/OR BRIGHTENING KERATIN FIBRES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-01-18 | — | — | WO | disclosed |
| WO-2006131234-A1 | COSMETIC COMPOSITIONS COMPRISING IONIC LIQUIDS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-12-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160009669-A1 | ONIUM SALT, LIQUID COMPOSITION CONTAINING SAID ONIUM SALT AND CELLULOSE, AND CELLULOSE RECOVERY METHOD | CEL, CROCC, ALG1 | SLC22A1 2500/4885ALDH1A1 4797/4885TP53 4153/4885 |
| US-20250122323-A1 | ONIUM SALT, BLOCKING AGENT DISSOCIATION CATALYST FOR BLOCKED ISOCYANATE, BLOCKED ISOCYANTE COMPOSITION INCLUDING BLOCKING AGENT DISSOCIATION CATALYST, THERMOSETTING RESIN COMPOSITION, AND CURED PRODUCT AND MANUFACTURING METHOD THEREFOR | KDM2B, O60361, IDH3B | SLC22A1 4626/4885ALDH1A1 1023/4885TP53 4345/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.